2024. SLC39A1 contributes to gemcitabine resistance of pancreatic ductal adenocarcinoma by activating AMPK signaling. Bangladesh Journal of Pharmacology. 19, 2 (Jun. 2024), 52–58. DOI:https://doi.org/10.3329/bjp.v19i2.72787.